Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis
Clinical trial NCT02424396 · COMPLETED
Trial details
- NCT number
- NCT02424396
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2019-10-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.